Medicine Supply Map

USP Medicine Supply Map

As supply chains grow more global and complex, digital transformation isn’t optional—it’s mission-critical. The USP Medicine Supply Map (MSM) is a powerful drug‑shortage intelligence platform that uses AI and predictive analytics to simplify, strengthen, and optimize supply chain management.

USP MSM provides clear, actionable intelligence that enables manufacturers, healthcare systems, distributors, buyers, and policymakers to make data‑driven decisions that helps reduce disruptions, prevent shortages, and strengthen supply chain resilience. It delivers proactive, real-time insights that surface risks early, helping organizations identify and address vulnerabilities before they impact patient care.

Your advantage with the USP Medicine Supply Map

The USP Medicine Supply Map helps you predict, protect, and plan with confidence. By combining trusted data, AI-powered analytics, and science-backed expertise, the USP MSM gives you clear, actionable visibility into vulnerabilities across the global medicine supply chain.

With the USP MSM, you gain more than a technology platform—you gain a strategic partner dedicated to strengthening the reliability and resilience of the world’s medicine supply. Together, we can build a healthier, safer future where everyone has access to the medicines they need.

Predictive Power

Predict potential drug shortages before they happen with early-warning indicators and advanced forecasting models

Leverage powerful accuracy. 100% of 2024 new injectable drug shortages flagged as high-risk before actual shortage
Benefit from early shortage detection. Identifies 50% of injectable shortages up to 4 months in advance
Unlock new opportunities. Capitalize on forecast trends and market shifts

Protective Insight

Protect your organization and patients by identifying risks early, understanding their drivers, and taking proactive steps to strengthen supply chain resilience

Traces FDFs, APIs, and offers KSMs mapping for full supply chain transparency
95% FDFs and 68% APIs mapped · 85% API volume mapped to manufacturing facilities
80% active NDCs mapped by country of origin to reveal geographic risks

Planning Precision

Plan with confidence using comprehensive data and real-time insights that support informed decision-making

Prioritize critical drugs. Focus on high-impact drugs essential to market stability
Optimize inventory and production. Adjust stock based on real-time risk assessment and gain insight for strengthening supply continuity
Plan with confidence. Use real-time intelligence to guide sourcing, procurement, policy development, and short- or long-term strategy

Features that power better visibility & planning

Supply chain mapping. End-to-end visibility
AI-driven prediction. Drug shortages forecasts
Risk driver analysis. Identified and quantified risk assessments
Market share intelligence. High-risk drug categories monitoring
Regulatory alerts. Emailed FDA notifications
Customizable dashboard. Adjustable, filterable views and user-defined watch lists
Reporting & transparency. Monthly data and model accuracy reporting

Enhance upstream visibility with the KSM Module

The USP Medicine Supply Map key starting materials (KSMs) add-on module extends visibility further upstream on the medicine supply chain. While MSM provides end-to-end insight from finished dosage form (FDFs) to active pharmaceutical ingredients (APIs), the KSM Module highlights the chemical building blocks behind U.S.-approved APIs.

This deeper insight helps decision-makers identify vulnerabilities sooner, mitigate risk, and strengthen supply chain resilience.

What MSM Delivers

Supply chain mapping. End-to-end visibility with integrated, trusted data for planning and coordination
AI-driven prediction. Forecasts drug shortages 4-12 months ahead
Risk driver analysis. Identifies and quantifies risks, using current market conditions and historical data to inform insights

Request a demo

The KSM Module

Full upstream visibility. Trace sourcing from KSMs " APIs " FDFs for complete upstream insight
Dependency mapping insight. Identify sole or limited source reliance and regional over dependence risks
Global KSMs tracking. Track across 22+ countries and key manufacturing regions

Request a demo

Related insights

Protective Purchasing: A Hidden Amplifier of Drug Shortages

Discover why well‑intentioned reactions can deepen supply disruptions—and what visibility and coordination can do to help stabilize access—through this USP Medicine Supply Map insight.

Read the blog

The Hidden Chokepoints in America's Medicine Supply Chain

Gain insight into upstream supply chain vulnerabilities with this USP Medicine Supply Map report that reveals Key Starting Materials (KSMs) have a high dependency on single-country sourcing and considerable geographic concentration.

Access the full report

2024 Drug Shortages Report

Identify the top medicines at risk and uncover the drivers behind persistent supply challenges, including pricing pressures, manufacturing delays, and geographic concentration.

Access the full report